Literature DB >> 8240106

Pseudo low penetrance in retinoblastoma. Fortuitous familial aggregation of sporadic cases caused by independently derived mutations in two large pedigrees.

F L Munier1, M X Wang, M A Spence, F Thonney, A Balmer, G Pescia, L A Donoso, A L Murphree.   

Abstract

OBJECTIVE: The disparate occurrence of few cases of retinoblastoma in the same extended pedigree confronts us with the unsolved problem of a low-penetrant autosomal-dominant trait vs fortuitous familial aggregation of sporadic cases. Determination as to whether the disease arises from a common inherited mutation or sporadic mutations has important implications for genetic counseling. This is illustrated in this report of two presumed low-penetrant retinoblastoma pedigrees characterized by two distantly affected relatives connected through apparently healthy carriers.
DESIGN: We mathematically modeled the inheritance patterns and calculated the a priori relative probabilities of heredity with low penetrance vs chance occurrence of independent mutations for each pedigree. The derived odds clearly show that the disease, which occurred twice in each family, most likely resulted from unrelated mutations. To prove this, extensive DNA testing was conducted, including determination of intragenic RB1 DNA sequence polymorphisms and screening for mutation using the polymerase chain reaction coupled with single-strand conformation polymorphism analysis. PATIENTS: All living key members from both pedigrees were included.
RESULTS: Consistent with our initial expectation, there was no common intragenic haplotype or common germ-line mutation that segregated with the disease phenotype in either of these two families.
CONCLUSIONS: We therefore conclude that collateral incidence of retinoblastoma in these two pedigrees occurred by chance and not according to autosomal-dominant inheritance with low penetrance. Furthermore, our data provide the first evidence, to our knowledge, that related individuals may have independent mutations involving an identical gene locus, giving rise to an artefactual inheritance pattern.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240106     DOI: 10.1001/archopht.1993.01090110073028

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Two sisters with Rett syndrome and non-identical paternally-derived microdeletions in the MECP2 gene.

Authors:  Lyndon G Rosser; Shane McKee; David S Millar; Hayley Archer; James Hughes; Rachel Butler; Nadia Chuzhanova; David N Cooper; Lazarus P Lazarou
Journal:  Genomic Med       Date:  2008-09-20

3.  Intra-individual plasticity of the TAZ gene leading to different heritable mutations in siblings with Barth syndrome.

Authors:  Lorenzo Ferri; Maria A Donati; Silvia Funghini; Catia Cavicchi; Viviana Pensato; Cinzia Gellera; Federica Natacci; Luigina Spaccini; Serena Gasperini; Frédéric M Vaz; David N Cooper; Renzo Guerrini; Amelia Morrone
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 4.  Recent advances in the gene map of inherited eye disorders: primary hereditary diseases of the retina, choroid, and vitreous.

Authors:  P J Rosenfeld; V A McKusick; J S Amberger; T P Dryja
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

Review 5.  Putative non-Mendelian transmission of retinoblastoma in males: a phenotypic segregation analysis of 150 pedigrees.

Authors:  F L Munier; L Arabien; P Flodman; M A Spence; G Pescia; H P Rutz; A L Murphree
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

6.  Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma.

Authors:  D R Lohmann; B Brandt; W Höpping; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.